Horse cloning sparks debate in America's breeding stables
By The Telegraph,
The Telegraph
| 04. 08. 2010
Zarela Olsen decided to clone her horse Capuchino, who was named Paso Fino "Horse of the Millennium" in 1999, before he died, investing $160,000 in the replicating services of a biotech company specializing in animal cloning.
Capuchino's genetic duplicate, Capuchino Forever, was born in May.
But breeders are unhappy with the idea, claiming that cloning threatens their industry, the Los Angeles Times reports.
"They smell money," Carol Harris, horse breeder and owner of Bo-Bett Farm near Ocala, told the paper. "They're looking for a shortcut to a great horse."
"Breeding is an art," she said. "Cloning is just replication."
Cloned horses are currently banned from competing in breed-sanctioned events, but that could change in the future.
The Stud Book and Registration Committee of the American Quarter Horse Assn., recently voted down a proposed rule change that would have allowed registration of clones.
But supporters of cloning claim the opposition stems from a lack of knowledge about the process.
"They're thinking it's growing Frankensteins in a lab, and that's simply not the case," said Karen Batra, spokeswoman for BIO, a 1,200-member...
Related Articles
By Carissa Wong, New Scientist | 07.08.2026
Healthy lambs have been born via an experimental form of in vitro fertilisation (IVF) that coaxes highly immature eggs to become mature ones in the lab. This is the first time the approach has been demonstrated in a large animal...
By Maggie Astor, The New York Times | 06.23.2026
Every year, patients undergo millions of in vitro fertilization procedures worldwide. Only a minority result in a live birth.
In an effort to improve the odds, scientists have developed an array of “add-ons” that could in theory identify the most...
By Carl Zimmer and Catrin Einhorn, The New York Times | 06.25.2026
The Trump administration and a company that is promising to bring long-gone animals back from extinction announced a partnership on Thursday to preserve cells, tissue and DNA from threatened and endangered species.
The company, Colossal Biosciences, said its goal was...
By Julianna LeMieux, Genetic Engineering & Biotechnology News | 04.14.2026
Twenty years ago, Sven Bocklandt, PhD, sought to create a hypoallergenic cat. He had the genetic engineering chops to do it, but the embryology was beyond his capabilities. At a small animal genetic engineering conference, known as TARC (Transgenic Animal...